Author

A. Cosma

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Research Focus:cell-cell communication· 2 Research Focus:differential expression· 2 Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1 Approach:deep learning· 1

Frequent Co-Authors

A. Floerchinger· 1 shared A. Golebiewska· 1 shared A. Lipsa· 1 shared A. Marchini· 1 shared A. Oudin· 1 shared A. Poli· 1 shared A. Rosenwald· 1 shared B. Nosirov· 1 shared

Activity by Year

2021-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Floerchinger

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

T-Cell-Mediated Killing in Glioblastoma Organoids induced by Adenoviral Delivery of the CIITA Transgene

I. Salvato, E. Klein, A. Poli, M. Rezaeipour, L. Ermini, B. Nosirov, A. Lipsa, A. Oudin, V. Baus, G. M. Dore, A. Cosma, A. Golebiewska, A. Marchini, S. P. Niclou

This study shows that adenoviral delivery of CIITA enhances T-cell mediated killing of glioblastoma organoids, with some MHC-II-independent immune responses observed.

bioRxiv · Jan 22, 2024 · PreprintCancer Biology

High-dimensional single-cell definition of CLL T cells identifies Galectin-9 as novel immunotherapy target

L. L. Cid, J. K. Leong, I. F. Botana, Y. Paul, M. Wierz, A. Floerchinger, S. Gonder, G. Pagano, M. Chazotte, K. Bestak, C. Schifflers, M. Iskar, T. Roider, F. Czernilofsky, P.-M. Bruch, , M. Seiffert

The paper defines CLL T cell subtypes and identifies Galectin-9 as a novel immunotherapy target through single-cell and multi-omics analyses.

bioRxiv · Dec 15, 2022 · PreprintCancer Biology

Standard PBMC cryopreservation selectively decreases detection of nine clinically-relevant T-cell markers

C. M. Capelle, S. Cire, W. Ammerlaan, M. Konstantinou, R. Balling, F. Betsou, A. Cosma, M. Ollert, F. Q. Hefeng

This study shows that standard PBMC cryopreservation reduces detection of nine T-cell markers but not others, highlighting potential issues in clinical trial interpretations.

bioRxiv · May 18, 2021Immunology